170 related articles for article (PubMed ID: 20586033)
1. Serine- and mannose-modified liposomal contrast agent for computed tomography: evaluation of the enhancement in rabbit liver VX-2 tumor model.
Okada M; Isoda T; Kumano S; Kagawa Y; Araki T; Onishi H; Hori M; Kim T; Motokui Y; Wada T; Murakami T
Contrast Media Mol Imaging; 2010; 5(3):140-6. PubMed ID: 20586033
[TBL] [Abstract][Full Text] [Related]
2. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
[TBL] [Abstract][Full Text] [Related]
3. Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.
Henning T; Weber AW; Bauer JS; Meier R; Carlsen JM; Sutton EJ; Prevrhal S; Ziegler SI; Feussner H; Daldrup-Link HE; Rummeny EJ
Acad Radiol; 2008 Mar; 15(3):342-9. PubMed ID: 18280932
[TBL] [Abstract][Full Text] [Related]
4. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
[TBL] [Abstract][Full Text] [Related]
5. Dual energy CT ventilation imaging after aerosol inhalation of iodinated contrast medium in rabbits.
Zhang LJ; Wang ZJ; Lu L; Zhu K; Chai X; Zhao YE; Peng J; Lu GM
Eur J Radiol; 2011 May; 78(2):266-71. PubMed ID: 21109377
[TBL] [Abstract][Full Text] [Related]
6. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
[TBL] [Abstract][Full Text] [Related]
7. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
Ma X; Samir AE; Holalkere NS; Sahani DV
AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of liposomal contrast agents for liver CT in healthy rabbits.
Petersein J; Franke B; Fouillet X; Hamm B
Invest Radiol; 1999 Jun; 34(6):401-9. PubMed ID: 10353032
[TBL] [Abstract][Full Text] [Related]
9. Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
Ghaghada KB; Sato AF; Starosolski ZA; Berg J; Vail DM
PLoS One; 2016; 11(3):e0152718. PubMed ID: 27031614
[TBL] [Abstract][Full Text] [Related]
10. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology.
Zheng J; Allen C; Serra S; Vines D; Charron M; Jaffray DA
Contrast Media Mol Imaging; 2010; 5(3):147-54. PubMed ID: 20586032
[TBL] [Abstract][Full Text] [Related]
11. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
[TBL] [Abstract][Full Text] [Related]
12. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
Awai K; Takada K; Onishi H; Hori S
Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Wolf KJ
Invest Radiol; 1995 Nov; 30(11):644-9. PubMed ID: 8557505
[TBL] [Abstract][Full Text] [Related]
14. CT imaging with iopromide liposomes in a rabbit model.
Krause W; Schönborn A; Rupp K
J Liposome Res; 2011 Sep; 21(3):229-36. PubMed ID: 21039317
[TBL] [Abstract][Full Text] [Related]
15. Improved visualization of vessels and hepatic tumors by micro-computed tomography (CT) using iodinated liposomes.
Montet X; Pastor CM; Vallée JP; Becker CD; Geissbuhler A; Morel DR; Meda P
Invest Radiol; 2007 Sep; 42(9):652-8. PubMed ID: 17700281
[TBL] [Abstract][Full Text] [Related]
16. Liver contrast enhancement in primates using iopromide liposomes.
Schmiedl UP; Krause W; Leike J; Nelson JA; Schuhmann-Giampieri G
Acad Radiol; 1995 Nov; 2(11):967-72. PubMed ID: 9419668
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.
Li C; Kan Z; Yang DJ; Kuang LR; Liu CW; Wright KC; Wallace S
Invest Radiol; 1994 Nov; 29(11):1006-13. PubMed ID: 7890508
[TBL] [Abstract][Full Text] [Related]
18. CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques.
Lee FT; Chosy SG; Naidu SG; Goldfarb S; Weichert JP; Bakan DA; Kuhlman JE; Tambeaux RH; Sproat IA
Radiology; 1997 May; 203(2):465-70. PubMed ID: 9114106
[TBL] [Abstract][Full Text] [Related]
19. Lipid soluble contrast agents for computed tomography of the liver: results with cholesteryl iopanoate.
Glazer GM; Longino MA; Schwendner SW; Counsell RE; Weichert JP
J Comput Assist Tomogr; 1983 Oct; 7(5):775-9. PubMed ID: 6886127
[TBL] [Abstract][Full Text] [Related]
20. Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver.
Jendrasiak GL; Frey GD; Heim RC
Invest Radiol; 1985 Dec; 20(9):995-1002. PubMed ID: 3000977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
